JHP Pharmaceuticals Enters Agreement to Produce Diagnostic Aid
PARSIPPANY, NJ October 18, 2011
--
JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile injectable products announced today that it has entered into an agreement with an undisclosed pharmaceutical company for the product transfer and registration batch production of a diagnostic aid.
Stuart Hinchen, president and CEO of JHP stated “Our record of cGMP compliance, coupled with comprehensive experience in manufacturing site transfers put us in the position to serve this important customer.”
Commenting on the successful completion of recent FDA and EMA audits in addition to agreements with six new customers, Hinchen noted, “Our Rochester, Michigan site has a 25 year history in contract manufacturing. This accomplishment was created by a quality-driven, experienced staff and a customer-centric approach. Since purchasing the plant in 2007, we have focused on growing our internal infrastructure to support expansion of our contract manufacturing services by investing in both our people and our facilities. Recent investments include a clinical filler and a 240 sq. ft. lyophilizer in addition to expanding our Manufacturing, Regulatory and Quality Teams.”
“JHP Pharmaceuticals has extensive experience working with products throughout their life cycle starting with clinical trial supplies, through regulatory approval, product launch and global commercialization providing customers with the right scale and experience to meet their product life cycle needs.”
About JHP Pharmaceuticals, LLC
JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations.
JHP’s sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, four lyophilizers and a clinical fill line. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.
JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 330 staff in the USA in its manufacturing, product development, regulatory, sales & marketing and corporate areas. For more information, please visit
www.jhppharma.com.
Additional Press Releases
|
07/25/11 |
|
JHP Pharmaceuticals to Produce Clinical Batches of Innovative Cardiac Drug |
 |
|
Webpage
|
PDF Format |
|
|
|
|
07/06/11 |
|
JHP Pharmaceuticals Enters Agreement To Produce Life-Saving Drug |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/05/11 |
|
JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®,
Coly-Mycin® M and Pitocin® |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/24/11 |
|
JHP Pharmaceuticals Announces Chief
Executive Officer Succession |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
03/28/11 |
|
JHP Pharmaceuticals Announces Multi-Year
Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
02/24/11 |
|
JHP Pharmaceuticals Enters Another Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
01/27/11 |
|
JHP Pharmaceuticals & Putney Inc. Announce Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/29/10 |
|
JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
05/10/10 |
|
JHP Pharmaceuticals Announces Successful
Completion of FDA and EMEA GMP Audits |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
09/28/09 |
|
JHP Announces FDA Approval for Dantrium IV, rapidly mixing in 20 seconds
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
08/20/08 |
|
JHP Pharmaceuticals & SpePharm complete
purchaseof Dantrium® (dantrolene sodium)
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/16/07 |
|
King Pharmaceuticals Completes Sale Of Rochester, Michigan Manufacturing Facility
To JHP Pharmaceuticals |
|
|
|
Webpage
|
PDF Format |
|
|
|
